GASTRIC INTESTINAL METAPLASIA
Clinical trials for GASTRIC INTESTINAL METAPLASIA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC INTESTINAL METAPLASIA trials appear
Sign up with your email to follow new studies for GASTRIC INTESTINAL METAPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common drug stop stomach cancer before it starts?
Disease control Recruiting nowThis study tests whether the drug pyrvinium can reverse early changes in the stomach lining that may lead to cancer. About 32 adults with gastric intestinal metaplasia and high-risk features will receive either pyrvinium or a placebo. The goal is to see if the drug reduces precan…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Phase: PHASE2 • Sponsor: Katherine Garman • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Bile acid pill may reverse stomach precancer in new trial
Disease control Recruiting nowThis study tests whether a medicine called ursodeoxycholic acid (UDCA) can reverse gastric intestinal metaplasia, a condition that raises stomach cancer risk. About 196 adults without H. pylori infection will take UDCA or a placebo daily for 6 months. Researchers will check if th…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New study aims to prevent stomach cancer by tracking early warning signs
Knowledge-focused Recruiting nowThis study is building a registry of 3,200 people with early stomach changes that can lead to cancer, such as gastric atrophy or intestinal metaplasia. Researchers will also include healthy people and those with stomach cancer for comparison. The goal is to learn which risk facto…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:23 UTC